20-year outcomes following conservative management of clinically localized prostate cancer.

@article{Albertsen200520yearOF,
  title={20-year outcomes following conservative management of clinically localized prostate cancer.},
  author={Peter C Albertsen and James A. Hanley and Judith T. Fine},
  journal={JAMA},
  year={2005},
  volume={293 17},
  pages={
          2095-101
        }
}
CONTEXT The appropriate therapy for men with clinically localized prostate cancer is uncertain. A recent study suggested an increasing prostate cancer mortality rate for men who are alive more than 15 years following diagnosis. OBJECTIVE To estimate 20-year survival based on a competing risk analysis of men who were diagnosed with clinically localized prostate cancer and treated with observation or androgen withdrawal therapy alone, stratified by age at diagnosis and histological findings… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 32 CITATIONS

KIF3a promotes proliferation and invasion via Wnt signaling in advanced prostate cancer.

  • Molecular cancer research : MCR
  • 2014
VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Prostate cancer in senior adults: over- or undertreated?

  • Wiener Medizinische Wochenschrift
  • 2009
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 19 REFERENCES

Histologic grading and clinical staging of carcinoma of the prostate

DF Gleason
  • Urologic Pathology
  • 1977
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Prevalence of prostate cancer among men with a prostate-specific antigen level of 4.0 ng per milliliter

IM Thompson, DK Pauler, PJ Goodman
  • N Engl J Med
  • 2004

Prevalence of prostate cancer among men with a prostate-specific antigen level of 4.0 ng per milliliter

IM Thompson, DK Pauler, PJ Goodman
  • N Engl J Med
  • 2004

Similar Papers